Pancreatic Cancer Research

ResearcherQingdao UniversityNo recent work listed

Wei Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4276-3255; OpenAlex author ID A5100441629. Sources: OpenAlex.

Their work

Papers
8 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
29
Papers, trials and grants by year

2015: 2 papers · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: 2 papers · 2022: 3 papers

Papers 8

  1. Liver Endothelium Microenvironment Promotes HER3-mediated Cell Growth in Pancreatic Ductal Adenocarcinoma. First author DOI 10.26502/jcsct.5079182↗
  2. The novel subclusters based on cancer-associated fibroblast for pancreatic adenocarcinoma. Co-author DOI 10.3389/fonc.2022.1045477↗
  3. Two Novel Nomograms Predicting the Risk and Prognosis of Pancreatic Cancer Patients With Lung Metastases: A Population-Based Study. Co-author DOI 10.3389/fpubh.2022.884349↗
  4. Genomic analyses identify biological processes of pancreatic cancer after radiotherapy First author DOI 10.21203/rs.3.rs-1178890/v1↗
  5. Nomogram Predicts Risk and Prognostic Factors for Bone Metastasis of Pancreatic Cancer: A Population-Based Analysis. Co-author DOI 10.3389/fendo.2021.752176↗
  6. NRG1 Gene Fusions Are Recurrent, Clinically Actionable Gene Rearrangements in KRAS Wild-Type Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-19-0191↗
  7. Mutated K-ras activates CDK8 to stimulate the epithelial-to-mesenchymal transition in pancreatic cancer in part via the Wnt/β-catenin signaling pathway. Co-author DOI 10.1016/j.canlet.2014.10.008↗
  8. Genomic expression profiling and bioinformatics analysis of pancreatic cancer. Co-author DOI 10.3892/mmr.2015.3917↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qing Bi · 2 shared papers, 2021–2022 · strength 0.29
  2. Hongwei Yang · 1 shared paper, 2022 · strength 0.20
  3. Guojie Zhao · 1 shared paper, 2022 · strength 0.20
  4. Hanming Gu · 1 shared paper, 2021 · strength 0.19
  5. Jing Li · 1 shared paper, 2021 · strength 0.19
  6. Rui Wang · 1 shared paper, 2022 · strength 0.15
  7. Moeez Ghani Rathore · 1 shared paper, 2022 · strength 0.15
  8. Ali Vaziri Gohar · 1 shared paper, 2022 · strength 0.15
  9. Mehrdad Zarei · 1 shared paper, 2022 · strength 0.15
  10. Omid Hajihassani · 1 shared paper, 2022 · strength 0.15
  11. Jonathan Robert Brody · 1 shared paper, 2022 · strength 0.15
  12. Jordan Michael Winter · 1 shared paper, 2022 · strength 0.15
  13. Joanna M. Karasinska · 1 shared paper, 2019 · strength 0.06
  14. Michael K.C. Lee · 1 shared paper, 2019 · strength 0.06
  15. Martin R. Jones · 1 shared paper, 2019 · strength 0.06
  16. Sharlene Gill · 1 shared paper, 2019 · strength 0.06
  17. Hui‐Li Wong · 1 shared paper, 2019 · strength 0.06
  18. James Thomas Topham · 1 shared paper, 2019 · strength 0.06
  19. Jennifer Jane Knox · 1 shared paper, 2019 · strength 0.06
  20. David F. Schaeffer · 1 shared paper, 2019 · strength 0.06
  21. Steve Gallinger · 1 shared paper, 2019 · strength 0.06
  22. Daniel John Renouf · 1 shared paper, 2019 · strength 0.06
  23. Malcolm J. Moore · 1 shared paper, 2019 · strength 0.06
  24. Wei Xu · 1 shared paper, 2015 · strength 0.05
  25. Yuqiang Li · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.